S

Sarepta Therapeutics
D

SRPT

18.200
USD
0.01
(0.06%)
مغلق
حجم التداول
59,562
الربح لكل سهم
-2
العائد الربحي
-
P/E
-7
حجم السوق
1,788,641,982
أصول ذات صلة
AMGN
AMGN
1.79
(0.60%)
298.52 USD
BIIB
BIIB
-1.170
(-0.88%)
132.000 USD
BMRN
BMRN
0.560
(0.98%)
57.750 USD
GILD
GILD
-0.760
(-0.68%)
110.760 USD
INCY
INCY
0.300
(0.44%)
68.470 USD
I
IONS
-0.450
(-1.03%)
43.190 USD
R
RCKT
0.04000
(1.39%)
2.92000 USD
REGN
REGN
-0.69
(-0.13%)
546.88 USD
VRTX
VRTX
2.24
(0.49%)
459.27 USD
المزيد
الأخبار المقالات

العنوان: Sarepta Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.